Animal immunization merges with innovative technologies: A new paradigm shift in antibody discovery

References

• Gray A, Bradbury ARM, Knappik A, Pluckthun A, Borrebaeck CAK, Dubel S. Animal-free alternatives and the antibody iceberg. Nat Biotechnol. 2020;38(11):1234–4. doi:10.1038/s41587-020-0687-9.
   PubMed Web of Science ®Google Scholar
• Finney J, Yeh CH, Kelsoe G, Kuraoka M. Germinal center responses to complex antigens. Immunol Rev. 2018;284(1):42–50. doi:10.1111/imr.12661.
   PubMed Web of Science ®Google Scholar
• Briney BS, Crowe JE Jr. Secondary mechanisms of diversification in the human antibody repertoire. Front Immunol. 2013;4:42. doi:10.3389/fimmu.2013.00042.
   PubMed Web of Science ®Google Scholar
• Tan J, Pieper K, Piccoli L, Abdi A, Perez MF, Geiger R, Tully CM, Jarrossay D, Ndungu FM, Wambua J, et al. A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens. Nature. 2016;529:105–09. doi:10.1038/nature16450.
   PubMed Web of Science ®Google Scholar
• Spencer S, Bethea D, Raju TS, Giles-Komar J, Feng Y. Solubility evaluation of murine hybridoma antibodies. MAbs. 2012;4(3):319–25. doi:10.4161/mabs.19869.
   PubMed Web of Science ®Google Scholar
• Parray HA, Shukla S, Samal S, Shrivastava T, Ahmed S, Sharma C, Kumar R. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives. Int Immunopharmacol. 2020;85:106639. doi:10.1016/j.intimp.2020.106639.
   PubMed Web of Science ®Google Scholar
• Gjetting T, Gad M, Frohlich C, Lindsted T, Melander MC, Bhatia VK, Grandal MM, Dietrich N, Uhlenbrock F, Galler GR, et al. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform. MAbs. 2019;11(4):666–80. doi:10.1080/19420862.2019.1596514.
   PubMed Web of Science ®Google Scholar
• Saggy I, Wine Y, Shefet-Carasso L, Nahary L, Georgiou G, Benhar I. Antibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining. Protein Eng Des Sel. 2012;25(10):539–49. doi:10.1093/protein/gzs060.
   PubMed Web of Science ®Google Scholar
• Rossant CJ, Carroll D, Huang L, Elvin J, Neal F, Walker E, Benschop JJ, Kim EE, Barry ST, Vaughan TJ. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes. MAbs. 2014;6(6):1425–38. doi:10.4161/mabs.34376.
   PubMed Web of Science ®Google Scholar
• Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27:1.
   PubMed Web of Science ®Google Scholar
• Frenzel A, Schirrmann T, Hust M. Phage display-derived human antibodies in clinical development and therapy. MAbs. 2016;8(7):1177–94. doi:10.1080/19420862.2016.1212149.
   PubMed Web of Science ®Google Scholar
• Osbourn J, Groves M, Vaughan T. From rodent reagents to human therapeutics using antibody guided selection. Methods. 2005;36(1):61–68. doi:10.1016/j.ymeth.2005.01.006.
   PubMed Web of Science ®Google Scholar
• Kaleli NE, Karadag M, Kalyoncu S. Phage display derived therapeutic antibodies have enriched aliphatic content: insights for developability issues. Proteins. 2019;87(7):607–18. doi:10.1002/prot.25685.
   PubMed Web of Science ®Google Scholar
• Jain T, Sun T, Durand S, Hall A, Houston NR, Nett JH, Sharkey B, Bobrowicz B, Caffry I, Yu Y, et al. Biophysical properties of the clinical-stage antibody landscape. Proc Natl Acad Sci U S A. 2017;114(5):944–49. doi:10.1073/pnas.1616408114.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li R, Jia F, Hu Z, Li Q, Wei Z. A microfluidic chip for screening high-producing hybridomas at single cell level. Lab Chip. 2020;20(21):4043–51. doi:10.1039/D0LC00847H.
   PubMed Web of Science ®Google Scholar
• Tiller T. Single B cell antibody technologies. N Biotechnol. 2011;28(5):453–57. doi:10.1016/j.nbt.2011.03.014.
   PubMed Web of Science ®Google Scholar
• Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, Ott RG, Anthony RM, Zebroski H, Hurley A, et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature. 2009;458:636–40. doi:10.1038/nature07930.
   PubMed Web of Science ®Google Scholar
• Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 2008;453(7195):667–71. doi:10.1038/nature06890.
   PubMed Web of Science ®Google Scholar
• Keating SM, Mizrahi RA, Adams MS, Asensio MA, Benzie E, Carter KP, Chiang Y, Edgar RC, Gautam BK, Gras A, et al. Generation of recombinant hyperimmune globulins from diverse B-cell repertoires. Nat Biotechnol. 2021. doi:10.1038/s41587-021-00894-8.
   PubMedGoogle Scholar
• Shembekar N, Hu H, Eustace D, Merten CA. Single-cell droplet microfluidic screening for antibodies specifically binding to target cells. Cell Rep. 2018;22(8):2206–15. doi:10.1016/j.celrep.2018.01.071.
   PubMed Web of Science ®Google Scholar
• Adler AS, Bedinger D, Adams MS, Asensio MA, Edgar RC, Leong R, Leong J, Mizrahi RA, Spindler MJ, Bandi SR, et al. A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library. MAbs. 2018;10(3):431–43. doi:10.1080/19420862.2018.1426422.
   PubMed Web of Science ®Google Scholar
• Reddy ST, Ge X, Miklos AE, Hughes RA, Kang SH, Hoi KH, Chrysostomou C, Hunicke-Smith SP, Iverson BL, Tucker PW, et al. Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat Biotechnol. 2010;28(9):965–69. doi:10.1038/nbt.1673.
   PubMed Web of Science ®Google Scholar
• Rajan S, Kierny MR, Mercer A, Wu J, Tovchigrechko A, Wu H, Dall'Acqua WF, Xiao X, Chowdhury PS. Recombinant human B cell repertoires enable screening for rare, specific, and natively paired antibodies. Commun Biol. 2018;1(1):5. doi:10.1038/s42003-017-0006-2.
   PubMedGoogle Scholar
• Wang B, DeKosky BJ, Timm MR, Lee J, Normandin E, Misasi J, Kong R, McDaniel JR, Delidakis G, Leigh KE, et al. Functional interrogation and mining of natively paired human VH:VL antibody repertoires. Nat Biotechnol. 2018;36(2):152–55. doi:10.1038/nbt.4052.
   PubMed Web of Science ®Google Scholar
• Goldstein LD, Chen YJ, Wu J, Chaudhuri S, Hsiao YC, Schneider K, Hoi KH, Lin Z, Guerrero S, Jaiswal BS, et al. Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies. Commun Biol. 2019;2(1):304. doi:10.1038/s42003-019-0551-y.
   PubMedGoogle Scholar
• Sormanni P, Aprile FA, Vendruscolo M. Third generation antibody discovery methods: in silico rational design. Chem Soc Rev. 2018;47(24):9137–57. doi:10.1039/C8CS00523K.
   PubMed Web of Science ®Google Scholar
• Nimrod G, Fischman S, Austin M, Herman A, Keyes F, Leiderman O, Hargreaves D, Strajbl M, Breed J, Klompus S, et al. Computational design of epitope-specific functional antibodies. Cell Rep. 2018;25(8):2121–31 e5. doi:10.1016/j.celrep.2018.10.081.
   PubMed Web of Science ®Google Scholar
• Richardson E, Galson JD, Kellam P, Kelly DF, Smith SE, Palser A, Watson S, Deane CM. A computational method for immune repertoire mining that identifies novel binders from different clonotypes, demonstrated by identifying anti-pertussis toxoid antibodies. MAbs. 2021;13(1):1869406. doi:10.1080/19420862.2020.1869406.
   PubMed Web of Science ®Google Scholar
• Wagar LE, Salahudeen A, Constantz CM, Wendel BS, Lyons MM, Mallajosyula V,Jatt LP, Adamska JZ, Blum LK, Gupta N, et al. Modeling human adaptive immune responses with tonsil organoids. Nat Med. 2021;27(1):125–35. doi:10.1038/s41591-020-01145-0.
   PubMed Web of Science ®Google Scholar
• Liu G, Zeng H, Mueller J, Carter B, Wang Z, Schilz J, Horny G, Birnbaum ME, Ewert S, Gifford DK. Antibody complementarity determining region design using high-capacity machine learning. Bioinformatics. 2020;36(7):2126–33. doi:10.1093/bioinformatics/btz895.
   PubMed Web of Science ®Google Scholar
• Graves J, Byerly J, Priego E, Makkapati N, Parish SV, Medellin B, Berrondo M. A review of deep learning methods for antibodies. Antibodies (Basel). 2020;9(2):9. doi:10.3390/antib9020012.
   Google Scholar
• Greiff V, Yaari G, Cowell L. Mining adaptive immune receptor repertoires for biological and clinical information using machine learning. Current Opinion in Systems Biology. 2020;24:109–19. doi:10.1016/j.coisb.2020.10.010.
   Google Scholar
• DeKosky BJ, Lungu OI, Park D, Johnson EL, Charab W, Chrysostomou C, Kuroda D, Ellington AD, Ippolito GC, Gray JJ, et al. Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires. Proc Natl Acad Sci U S A. 2016;113(19):E2636–45. doi:10.1073/pnas.1525510113.
   PubMed Web of Science ®Google Scholar
• Akbar R, Robert PA, Pavlovic M, Jeliazkov JR, Snapkov I, Slabodkin A, Weber CR, Scheffer L, Miho E, Haff IH, et al. A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding. Cell Rep. 2021;34(11):108856. doi:10.1016/j.celrep.2021.108856.
   PubMed Web of Science ®Google Scholar
• Papageorgiou L, Maroulis D, Chrousos GP, Eliopoulos E, Vlachakis D. Antibody clustering using a machine learning pipeline that fuses genetic, structural, and physicochemical properties. Adv Exp Med Biol. 2020;1194:41–58.
   PubMed Web of Science ®Google Scholar
• Csepregi L, Ehling RA, Wagner B, Reddy ST. Immune literacy: reading, writing, and editing adaptive immunity. iScience. 2020;23(9):101519. doi:10.1016/j.isci.2020.101519.
   PubMed Web of Science ®Google Scholar
• Marks C, Deane CM. How repertoire data are changing antibody science. J Biol Chem. 2020;295(29):9823–37. doi:10.1074/jbc.REV120.010181.
   PubMed Web of Science ®Google Scholar
• Rees AR. Understanding the human antibody repertoire. MAbs. 2020;12(1):1729683. doi:10.1080/19420862.2020.1729683.
   PubMed Web of Science ®Google Scholar
• Amimeur T, Shaver JM, Ketchem RR, Taylor JA, Clark RH, Smith J, Van Citters D, Siska CC, Smidt P, Sprague M, et al. Designing feature-controlled humanoid antibody discovery libraries using generative adversarial networks. bioRxiv. 2020;2020:12.024844.
   Google Scholar
• Shin J-E, Riesselman AJ, Kollasch AW, McMahon C, Simon E, Sander C, Manglik A, Kruse AC, Marks DS. Protein design and variant prediction using autoregressive generative models. bioRxiv. 2021;757252.
   Google Scholar
• Liu S, Wang S, Lu S. DNA immunization as a technology platform for monoclonal antibody induction. Emerg Microbes Infect. 2016;5(1):e33. doi:10.1038/emi.2016.27.
   PubMedGoogle Scholar
• Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261–79.
   PubMed Web of Science ®Google Scholar
• Tuccori M, Ferraro S, Convertino I, Cappello E, Valdiserra G, Blandizzi C, Maggi F, Focosi D. Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline. MAbs. 2020;12(1):1854149. doi:10.1080/19420862.2020.1854149.
   PubMed Web of Science ®Google Scholar